1. Home
  2. KROS vs CLNE Comparison

KROS vs CLNE Comparison

Compare KROS & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • CLNE
  • Stock Information
  • Founded
  • KROS 2015
  • CLNE 2001
  • Country
  • KROS United States
  • CLNE United States
  • Employees
  • KROS N/A
  • CLNE N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • CLNE Natural Gas Distribution
  • Sector
  • KROS Health Care
  • CLNE Utilities
  • Exchange
  • KROS Nasdaq
  • CLNE Nasdaq
  • Market Cap
  • KROS 565.0M
  • CLNE 526.3M
  • IPO Year
  • KROS 2020
  • CLNE 2007
  • Fundamental
  • Price
  • KROS $15.71
  • CLNE $2.63
  • Analyst Decision
  • KROS Buy
  • CLNE Strong Buy
  • Analyst Count
  • KROS 14
  • CLNE 5
  • Target Price
  • KROS $20.56
  • CLNE $3.59
  • AVG Volume (30 Days)
  • KROS 370.6K
  • CLNE 1.5M
  • Earning Date
  • KROS 11-05-2025
  • CLNE 11-05-2025
  • Dividend Yield
  • KROS N/A
  • CLNE N/A
  • EPS Growth
  • KROS N/A
  • CLNE N/A
  • EPS
  • KROS 0.47
  • CLNE N/A
  • Revenue
  • KROS $232,844,000.00
  • CLNE $420,579,000.00
  • Revenue This Year
  • KROS $5,998.31
  • CLNE $3.49
  • Revenue Next Year
  • KROS N/A
  • CLNE $1.71
  • P/E Ratio
  • KROS $33.68
  • CLNE N/A
  • Revenue Growth
  • KROS 85820.30
  • CLNE 4.08
  • 52 Week Low
  • KROS $9.12
  • CLNE $1.30
  • 52 Week High
  • KROS $72.37
  • CLNE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • KROS 53.11
  • CLNE 51.20
  • Support Level
  • KROS $15.00
  • CLNE $2.54
  • Resistance Level
  • KROS $16.57
  • CLNE $2.79
  • Average True Range (ATR)
  • KROS 0.53
  • CLNE 0.14
  • MACD
  • KROS -0.06
  • CLNE -0.01
  • Stochastic Oscillator
  • KROS 47.77
  • CLNE 20.59

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: